Gleason grading system (English Wikipedia)

Ruela-de-Sousa RR, Hoekstra E, Hoogland AM, Souza Queiroz KC, Peppelenbosch MP, Stubbs AP, et al. (April 2016). "Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential". European Urology. 69 (4): 710–719. doi:10.1016/j.eururo.2015.06.040. PMID 26159288.
Li J, Wang Z (February 2016). "The pathology of unusual subtypes of prostate cancer". Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 28 (1): 130–143. doi:10.3978/j.issn.1000-9604.2016.01.06. PMC 4779761. PMID 27041935.
Epstein JI, Allsbrook WC, Amin MB, Egevad LL (September 2005). "The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma". The American Journal of Surgical Pathology. 29 (9): 1228–1242. doi:10.1097/01.pas.0000173646.99337.b1. PMID 16096414. S2CID 7428768.
Humphrey PA (March 2004). "Gleason grading and prognostic factors in carcinoma of the prostate". Modern Pathology. 17 (3): 292–306. doi:10.1038/modpathol.3800054. PMID 14976540.
Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, et al. (May 2013). "Contemporary grading for prostate cancer: implications for patient care". European Urology. 63 (5): 892–901. doi:10.1016/j.eururo.2012.10.015. PMID 23092544.

newsbank.com

Ruela-de-Sousa RR, Hoekstra E, Hoogland AM, Souza Queiroz KC, Peppelenbosch MP, Stubbs AP, et al. (April 2016). "Low-Molecular-Weight Protein Tyrosine Phosphatase Predicts Prostate Cancer Outcome by Increasing the Metastatic Potential". European Urology. 69 (4): 710–719. doi:10.1016/j.eururo.2015.06.040. PMID 26159288.
Li J, Wang Z (February 2016). "The pathology of unusual subtypes of prostate cancer". Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 28 (1): 130–143. doi:10.3978/j.issn.1000-9604.2016.01.06. PMC 4779761. PMID 27041935.
Epstein JI, Allsbrook WC, Amin MB, Egevad LL (September 2005). "The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma". The American Journal of Surgical Pathology. 29 (9): 1228–1242. doi:10.1097/01.pas.0000173646.99337.b1. PMID 16096414. S2CID 7428768.
Humphrey PA (March 2004). "Gleason grading and prognostic factors in carcinoma of the prostate". Modern Pathology. 17 (3): 292–306. doi:10.1038/modpathol.3800054. PMID 14976540.
Brimo F, Montironi R, Egevad L, Erbersdobler A, Lin DW, Nelson JB, et al. (May 2013). "Contemporary grading for prostate cancer: implications for patient care". European Urology. 63 (5): 892–901. doi:10.1016/j.eururo.2012.10.015. PMID 23092544.

Li J, Wang Z (February 2016). "The pathology of unusual subtypes of prostate cancer". Chinese Journal of Cancer Research = Chung-Kuo Yen Cheng Yen Chiu. 28 (1): 130–143. doi:10.3978/j.issn.1000-9604.2016.01.06. PMC 4779761. PMID 27041935.

Epstein JI, Allsbrook WC, Amin MB, Egevad LL (September 2005). "The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma". The American Journal of Surgical Pathology. 29 (9): 1228–1242. doi:10.1097/01.pas.0000173646.99337.b1. PMID 16096414. S2CID 7428768.

Sperling D. "Revisions of the Gleason grading system make it more accurate". Sperling Prostate Center. Retrieved 31 March 2016.

Albertsen, Peter C. (1 May 2006). "How to interpret Gleason score in contemporary biopsy". Urology Times. Archived from the original on 2006-11-23. (URL is live, but appear corrupted compared to archived version.)

"Male Genital Pathology". The Internet Pathology Laboratory for Medical Education. The University of Utah, Eccles Health Sciences Library. Retrieved 2009-05-13.